Eliminating taxpayer-funded coverage for experimental gender modification procedures in federal health plans is a reasonable policy decision. The administration is simply removing coverage for chemical and surgical interventions that alter sex traits, not denying anyone employment or basic healthcare. Federal workers retain comprehensive health benefits while this specific category of elective procedures is excluded from coverage starting in 2026.